Coloplast A/S Market Share AnalysisSummaryGlobalData's medical devices report, 'Coloplast A/S Market Share Analysis' provides in-depth information on Coloplast's market position in the different medical equipment markets it operates in. The report provides Coloplast's market share information in three key market categories ' Advanced Wound Management, Ostomy Drainage Bags, and Incontinence Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Scope- Global company shares (in Revenues) information for the key markets Coloplast operates in ' Wound Care Management and Nephrology and Urology Devices. Other Key players covered include ConvaTec, Coloplast, Covidien, Smith & Nephew, Ethicon, Kinetic Concepts (KCI), Fresenius Medical Care, Svenska Celulosa Aktiebolaget SCA, Baxter International, Gambro, Kimberly-Clark, and B. Braun Melsungen, among others.- Coloplast's company shares (in Revenues) information for all the key countries the company has presence in ' United States, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil. - Coloplast's company shares (in Revenues) information for all the key market categories the company has presence in ' Advanced Wound Management, Ostomy Drainage Bags, and Incontinence Devices. - All the key data-points are for 2009 and cover all the key regions ' North America, Europe, Asia Pacific (APAC), South Central America (SCA), and Middle East and Africa (MEA).- Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries.- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in.- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any ' Mergers & Acquisitions (M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.Reasons to buy- Develop sales and marketing strategies by identifying who-stands-where in the markets, Coloplast operates in.- Plan your competition strategies by identifying the company's shares in the markets and geographic regions it operates in.- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Coloplast's market positions.
The document discusses various theories of motivation in the workplace, including:
- Google founders motivate employees by allowing them to pursue their interests and providing amenities like colorful offices and food.
- Herzberg's theory distinguishes between intrinsic motivators like achievement and extrinsic motivators like pay that don't necessarily motivate.
- Maslow's hierarchy of needs proposes that lower level needs must be met before higher ones motivate.
- McGregor's Theory X and Y describe assumptions managers have about motivating workers through fear versus commitment to goals.
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoReportLinker.com
ReportLinker and Findout use data analytics technologies to aggregate and normalize data from a wide range of sources to help researchers and analysts find relevant information more efficiently. The companies' core competency lies in both search and data analytics capabilities. Their natural language processing platform analyzes millions of documents daily to extract and structure concepts, relationships, and sentiments to improve users' productivity. Open data initiatives have helped the businesses by providing more content to incorporate, though most value comes from backend processing rather than raw data access. The companies aim to continue enhancing data discovery and contextualization of results.
This graphic shows Samsung's customers are still loyal: 86% of Samsung Customers would consider Samsung next time they upgrade their smartphone. More info on reportlinker.com/inisght
This document provides a summary of a report on the European branded coffee shop market in 23 countries. Some key points:
- It examines the size and growth of the branded coffee shop market in each country from 2009-2015. Several countries like Poland and Spain saw strong growth over 10% in 2011-2012.
- Market leaders like Starbucks, Costa Coffee and Coffee Fellows are profiled for each country along with operating statistics and strategies. Consumer trends toward convenience and sustainability are also discussed.
- Challenges facing the industry like economic uncertainty and high rents are analyzed. Success factors include quality coffee, food offerings and a strong brand. The growth potential of each market is evaluated based on GDP per capita and existing
Allegra's definitive annual study on the UK branded coffee shop market is now available; with insight from over 25,000 consumers the report provides an authoritative view of the market.Drawing on more than 12 years in-depth research, it is considered to be the bible of the coffee sector.KEY AREAS COVERED' Market size and growth projections for the total UK market' Impact of recent economic downturn on trading performance' Key player profiles, including financial performance, pricing analysis and forecasts' Importance of ethical and sustainability issues' Key success factors and market trends' Opportunities and challenges for suppliers' Consumer coffee consumption patterns' Consumer brand awareness and perceptions of key players' Differences between customer demographics, including age, gender, occupation and location by the reportSOURCE OF INFORMATION' Interviews with CEOs, managing directors, senior managers and store managers of major industry players, including:' leading UK coffee and food-focused chains' major coffee roasters and key equipment suppliers' non-specialist players including department stores, supermarkets, bookstores' leading property companies, letting agents and landlords' local authorities' Online surveys with UK coffee shop visitors' Desk research including: News articles and trade press, the Internet and company websites,industry associations, published accounts, data supplied by operators' In-store observations and analysis
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
WinterGreen Research announces that it has published a new study Wireless Infrastructure: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. Next generation mission critical systems are leveraging new technology. The 2013 study has 554 pages, 245 tables and figures. Worldwide Wireless Infrastructure markets are poised to achieve significant growth as Building out core networks and backhaul for smart phones.A smart phone is not very smart if the infrastructure can't support its applications. In response to the high growth smart phone markets, wireless infrastructure promises to grow dramatically in the near term.. Wireless Infrastructure technologies include WiMax, LTE, 4G and HSPA. These technologies are driving much higher capacity from the base station back to the fiber core. Fiber core is putting extreme pressure on provider's infrastructure and backhaul networks.WinterGreen Research predicts that the dramatic growth of wireless infrastructure is based on the growth of smart phones to a one trillion market by 2019, serving an installed base of 8.5 billion, many people having more than one smart phone. Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019, new markets evolved because of the value that apps provide to smart phones, mobile devices, tablets, and the Internet of things.According to Susan Eustis, lead author of the study, 'Wireless Infrastructure is being installed to upgrade core networks and upgrade backhaul and base stations to make systems more modern. Infrastructure for the Internet and for smart mobile devices creates demand for more sophisticated web development and web applications that in turn depend on more sophisticated infrastructure. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Modern systems represent a significant aspect of Internet market evolution.'The proportions of wireless infrastructure market industry segments are expected to remain much as they are, with the small cells and femtocells achieving strong growth on the access side, the core infrastructure must be upgraded to support the added backhaul backbone infrastructure. Wireless apps are expected to achieve $37 trillion revenue by 2019. This unbelievable growth occurs as the Internet is expanded to implement the interconnection of everything.Digital devices proliferate, machine to machine capabilities vastly expand instrumentation. The digital devices become the engine of a world economy, with apps collecting pennies a day for millions of apps from 8.5 billion people with smart phones by 2019.
The document discusses various theories of motivation in the workplace, including:
- Google founders motivate employees by allowing them to pursue their interests and providing amenities like colorful offices and food.
- Herzberg's theory distinguishes between intrinsic motivators like achievement and extrinsic motivators like pay that don't necessarily motivate.
- Maslow's hierarchy of needs proposes that lower level needs must be met before higher ones motivate.
- McGregor's Theory X and Y describe assumptions managers have about motivating workers through fear versus commitment to goals.
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoReportLinker.com
ReportLinker and Findout use data analytics technologies to aggregate and normalize data from a wide range of sources to help researchers and analysts find relevant information more efficiently. The companies' core competency lies in both search and data analytics capabilities. Their natural language processing platform analyzes millions of documents daily to extract and structure concepts, relationships, and sentiments to improve users' productivity. Open data initiatives have helped the businesses by providing more content to incorporate, though most value comes from backend processing rather than raw data access. The companies aim to continue enhancing data discovery and contextualization of results.
This graphic shows Samsung's customers are still loyal: 86% of Samsung Customers would consider Samsung next time they upgrade their smartphone. More info on reportlinker.com/inisght
This document provides a summary of a report on the European branded coffee shop market in 23 countries. Some key points:
- It examines the size and growth of the branded coffee shop market in each country from 2009-2015. Several countries like Poland and Spain saw strong growth over 10% in 2011-2012.
- Market leaders like Starbucks, Costa Coffee and Coffee Fellows are profiled for each country along with operating statistics and strategies. Consumer trends toward convenience and sustainability are also discussed.
- Challenges facing the industry like economic uncertainty and high rents are analyzed. Success factors include quality coffee, food offerings and a strong brand. The growth potential of each market is evaluated based on GDP per capita and existing
Allegra's definitive annual study on the UK branded coffee shop market is now available; with insight from over 25,000 consumers the report provides an authoritative view of the market.Drawing on more than 12 years in-depth research, it is considered to be the bible of the coffee sector.KEY AREAS COVERED' Market size and growth projections for the total UK market' Impact of recent economic downturn on trading performance' Key player profiles, including financial performance, pricing analysis and forecasts' Importance of ethical and sustainability issues' Key success factors and market trends' Opportunities and challenges for suppliers' Consumer coffee consumption patterns' Consumer brand awareness and perceptions of key players' Differences between customer demographics, including age, gender, occupation and location by the reportSOURCE OF INFORMATION' Interviews with CEOs, managing directors, senior managers and store managers of major industry players, including:' leading UK coffee and food-focused chains' major coffee roasters and key equipment suppliers' non-specialist players including department stores, supermarkets, bookstores' leading property companies, letting agents and landlords' local authorities' Online surveys with UK coffee shop visitors' Desk research including: News articles and trade press, the Internet and company websites,industry associations, published accounts, data supplied by operators' In-store observations and analysis
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
WinterGreen Research announces that it has published a new study Wireless Infrastructure: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. Next generation mission critical systems are leveraging new technology. The 2013 study has 554 pages, 245 tables and figures. Worldwide Wireless Infrastructure markets are poised to achieve significant growth as Building out core networks and backhaul for smart phones.A smart phone is not very smart if the infrastructure can't support its applications. In response to the high growth smart phone markets, wireless infrastructure promises to grow dramatically in the near term.. Wireless Infrastructure technologies include WiMax, LTE, 4G and HSPA. These technologies are driving much higher capacity from the base station back to the fiber core. Fiber core is putting extreme pressure on provider's infrastructure and backhaul networks.WinterGreen Research predicts that the dramatic growth of wireless infrastructure is based on the growth of smart phones to a one trillion market by 2019, serving an installed base of 8.5 billion, many people having more than one smart phone. Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019, new markets evolved because of the value that apps provide to smart phones, mobile devices, tablets, and the Internet of things.According to Susan Eustis, lead author of the study, 'Wireless Infrastructure is being installed to upgrade core networks and upgrade backhaul and base stations to make systems more modern. Infrastructure for the Internet and for smart mobile devices creates demand for more sophisticated web development and web applications that in turn depend on more sophisticated infrastructure. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Modern systems represent a significant aspect of Internet market evolution.'The proportions of wireless infrastructure market industry segments are expected to remain much as they are, with the small cells and femtocells achieving strong growth on the access side, the core infrastructure must be upgraded to support the added backhaul backbone infrastructure. Wireless apps are expected to achieve $37 trillion revenue by 2019. This unbelievable growth occurs as the Internet is expanded to implement the interconnection of everything.Digital devices proliferate, machine to machine capabilities vastly expand instrumentation. The digital devices become the engine of a world economy, with apps collecting pennies a day for millions of apps from 8.5 billion people with smart phones by 2019.
This document is a fax order form for reports from ReportLinker, which provides industry reports, company profiles, and market statistics. It contains fields for customers to provide contact and billing information as well as select a payment method of credit card, wire transfer, or check in order to place an order for reports. The form directs customers to fax the completed form back to ReportLinker offices in either Europe, the Middle East, and Africa or Asia, Oceania, and America depending on location.
This document is a fax order form for industry reports and company profiles from ReportLinker. It contains fields for customers to provide their contact and shipping information as well as payment details including credit card number, expiration date, and CVV. The form also lists ReportLinker's fax numbers for customers in different regions to submit their orders.
This very short document contains a single word - "TEST" - with no other context provided. It is not possible to provide a meaningful summary in 3 sentences or less given the extremely limited information.
Global Electric Resistance Welded Pipes IndustryReportLinker.com
This report analyzes the worldwide markets for Electric Resistance Welded Pipes in Thousand Tons by the following Product Segments: Mechanical Steel Tubing, Structural Tubing, Structural Steel Pipes, Pressure Tubing, Standard Pipes, Oil Country Tubular Goods, and Line Pipes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 181 companies including many key and niche players such as Al Jazeera Steel Products Company SAOG, Arabian Pipes Company, ArcelorMittal SA, ERW Pipes Portfolio of ArcelorMittal ChelPipe, Choo Bee Metal Industries Berhad, EVRAZ North America, JFE Steel Corporation, Maharashtra Seamless Limited, Melewar Industrial Group Berhad, Nippon Steel & Sumitomo Metal Corporation, Northwest Pipe Company, OAO TMK, TMK IPSCO, PT Bakrie Pipe Industries, Salzgitter Mannesmann Line Pipe GmbH, Tata Steel Europe, Techint Group SpA, Tenaris S.A., TenarisSiderca, Ternium S.A., United States Steel Corporation, United Metallurgical Company /OMK, Welspun Corp Ltd., Wheatland Tube Company, and Select Products of Wheatland Tube Company. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
This report analyzes the worldwide markets for Wireless Gaming in US$ Million by the following Product Segments: Messaging Based Wireless Gaming, Browser/Web Based Wireless Gaming, and Downloadable Wireless Gaming. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 90 companies including many key and niche players such as Blockdot, Inc., DeNA Co., Ltd., Electronic Arts, Inc., Gameloft SA,GAMEVIL, GREE International, Inc., Glu Mobile Inc., GigaMedia Limited, HandyGames, I-play, Itsmy
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
Hyperalgesia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Hyperalgesia Global Clinical Trials Review, H1, 2013" provides data on the Hyperalgesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperalgesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperalgesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
Genital Herpes Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Genital Herpes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
Overview: There are a number of technologies that may be deployed that all provide the ability for devices to "discover" one another, although over different distances ranging from centimeters (Near Field Communications), to meters (Bluetooth), to 10s of meters (Wi-Fi). They also all provide the ability for the devices to communicate directly with one another without a centralized network. Some of these use direct communication as their primary mode of communication e.g. NFC or RFID. Others are more traditional networks which provide direct communication ability as an adjunct to their primary network functions e.g. LTE-Direct or Wi-Fi Direct. Most of the short-term drivers for proximity-based services will be mobile advertising and social networking, especially friend-finder services or dating services, and gaming. In the longer term, other applications will come into play within the scope of the so called Internet of Things. The challenge and opportunity for network operators will be to develop new user scenarios and even new business models to generate revenues from these services. This research uncovers opportunities that will be both beneficial and disruptive to the existing ecosystem and value chain. This research is must reading for any company that is considering offerings within proximity and direct communications and any company that wants to stay ahead of the crowd in terms of preparation for these disruptive technologies. Target Audience: ' Mobile network operators' Industry verticals of all types' Wireless device manufacturers' Network infrastructure companies' Advertising agencies, brands, and merchants' Social networks, advertising, and content providers' Proximity, location, and direct communications vendors Key Report Benefits: ' Market forecasts for each significant technology/solution approach' Recognize the upcoming role and importance of LTE Direct compared to other solutions' Analysis of the major vendors focused on proximity and direct communications solutions' Understand the relationship between proximity, direct communications and the Internet of Things' Understand the technical and business-related differences between proximity/presence and location' Identify each of the major technologies/solutions for proximity detection, location determination, and direct communications' Evaluation of the market for major applications including public safety, social networking, advertising, the Internet of Things, and general location services Select Companies in Report: ' 3M Company' Alcatel-Lucent' iSIGN' LG' Nokia' Samsung' Qualcomm' Verizon Wireless
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This document provides a summary and table of contents for a 900-page report analyzing the clinical chemistry and immunodiagnostic markets in five major European countries. The report explores trends, evaluates competitors, and identifies opportunities in these evolving markets. It contains estimates of test volumes, sales forecasts by category and country, and competitive profiles of leading suppliers.
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
Bradycardia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bradycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bradycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acid Indigestion / Heartburn/ Pyrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
This document is a report on the China iron ore mining industry in 2013. It provides an overview of the industry, including its definition and development history. It analyzes the macroeconomic environment and discusses factors like policy, upstream/downstream industries. It also examines the international and domestic markets. Key data on the industry from 2008-2012 is presented, including numbers of enterprises, employees, assets, output, sales, profits and trade. The competitive landscape and strategies of major companies are evaluated. The report concludes with discussions of development trends, investment environment and new technologies in the industry.
This document provides a summary and table of contents of the "World Biomass Report" published in November 2012. The report examines the global biomass market and finds that while it suffered during the economic downturn due to low coal prices and supply issues, the sector began growing again in 2010 as coal prices rose. Most biomass plants rely on wood pellets imported from North America, though suppliers from other regions like Russia and Australia aim to compete in the market. The full report contains detailed information on biomass resources, technologies, logistics, investments and policies on a global and national level.
This report provides an overview of the global biofuels industry in 2012. It summarizes production and policies related to first, second, and third generation biofuels in countries around the world. The report finds that 2009 was a difficult year for the biofuels industry due to low oil prices and reduced demand. However, projects using diverse feedstocks or next generation technologies like cellulosics and algae continued to receive investment. The report includes sections on biofuel production trends, technologies, environmental impacts, and policies in regions like Europe, the USA, and individual European countries.
This report analyzes the current state of various renewable energy technologies including hydropower, wind, solar, biomass, biofuels, and geothermal. It examines the market size and outlook for each technology by region, discusses the advantages and disadvantages of different renewable sources, and assesses the development status and future potential of the renewable energy industry globally. The report also profiles major renewable energy companies and evaluates government policies and industry support programs around the world.
This report provides an overview of the global solar photovoltaic (PV) market. It outlines key industry data like global solar capacity, production figures, and forecasts for future growth. It also examines major country markets and discusses the advantages, challenges, and components of the solar PV industry. The report analyzes factors such as government incentives, technology developments, and manufacturing trends that are shaping the future of the solar industry.
Inguinal Hernia Global Clinical Trials Review, H1, 2013ReportLinker.com
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Inguinal Hernia Global Clinical Trials Review, H1, 2013" provides data on the Inguinal Hernia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inguinal Hernia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inguinal Hernia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Cancer Cachexia Global Clinical Trials Review, H1, 2013ReportLinker.com
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Cancer Cachexia Global Clinical Trials Review, H1, 2013" provides data on the Cancer Cachexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cancer Cachexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cancer Cachexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Pompe Disease Global Clinical Trials Review, H1, 2013ReportLinker.com
This document summarizes a report on clinical trials for Pompe disease from January 2013. It provides an overview of the number and location of trials worldwide in the first half of 2013. The US, Germany, and China had the most trials. The trials were mostly in late phases and investigated drugs from companies like Genzyme and Sanofi. The report analyzed trial trends over time and provided profiles of top trial sponsors.
How to Implement a Real Estate CRM SoftwareSalesTown
To implement a CRM for real estate, set clear goals, choose a CRM with key real estate features, and customize it to your needs. Migrate your data, train your team, and use automation to save time. Monitor performance, ensure data security, and use the CRM to enhance marketing. Regularly check its effectiveness to improve your business.
This document is a fax order form for reports from ReportLinker, which provides industry reports, company profiles, and market statistics. It contains fields for customers to provide contact and billing information as well as select a payment method of credit card, wire transfer, or check in order to place an order for reports. The form directs customers to fax the completed form back to ReportLinker offices in either Europe, the Middle East, and Africa or Asia, Oceania, and America depending on location.
This document is a fax order form for industry reports and company profiles from ReportLinker. It contains fields for customers to provide their contact and shipping information as well as payment details including credit card number, expiration date, and CVV. The form also lists ReportLinker's fax numbers for customers in different regions to submit their orders.
This very short document contains a single word - "TEST" - with no other context provided. It is not possible to provide a meaningful summary in 3 sentences or less given the extremely limited information.
Global Electric Resistance Welded Pipes IndustryReportLinker.com
This report analyzes the worldwide markets for Electric Resistance Welded Pipes in Thousand Tons by the following Product Segments: Mechanical Steel Tubing, Structural Tubing, Structural Steel Pipes, Pressure Tubing, Standard Pipes, Oil Country Tubular Goods, and Line Pipes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 181 companies including many key and niche players such as Al Jazeera Steel Products Company SAOG, Arabian Pipes Company, ArcelorMittal SA, ERW Pipes Portfolio of ArcelorMittal ChelPipe, Choo Bee Metal Industries Berhad, EVRAZ North America, JFE Steel Corporation, Maharashtra Seamless Limited, Melewar Industrial Group Berhad, Nippon Steel & Sumitomo Metal Corporation, Northwest Pipe Company, OAO TMK, TMK IPSCO, PT Bakrie Pipe Industries, Salzgitter Mannesmann Line Pipe GmbH, Tata Steel Europe, Techint Group SpA, Tenaris S.A., TenarisSiderca, Ternium S.A., United States Steel Corporation, United Metallurgical Company /OMK, Welspun Corp Ltd., Wheatland Tube Company, and Select Products of Wheatland Tube Company. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
This report analyzes the worldwide markets for Wireless Gaming in US$ Million by the following Product Segments: Messaging Based Wireless Gaming, Browser/Web Based Wireless Gaming, and Downloadable Wireless Gaming. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 90 companies including many key and niche players such as Blockdot, Inc., DeNA Co., Ltd., Electronic Arts, Inc., Gameloft SA,GAMEVIL, GREE International, Inc., Glu Mobile Inc., GigaMedia Limited, HandyGames, I-play, Itsmy
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
Hyperalgesia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Hyperalgesia Global Clinical Trials Review, H1, 2013" provides data on the Hyperalgesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperalgesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperalgesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
Genital Herpes Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Genital Herpes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
Overview: There are a number of technologies that may be deployed that all provide the ability for devices to "discover" one another, although over different distances ranging from centimeters (Near Field Communications), to meters (Bluetooth), to 10s of meters (Wi-Fi). They also all provide the ability for the devices to communicate directly with one another without a centralized network. Some of these use direct communication as their primary mode of communication e.g. NFC or RFID. Others are more traditional networks which provide direct communication ability as an adjunct to their primary network functions e.g. LTE-Direct or Wi-Fi Direct. Most of the short-term drivers for proximity-based services will be mobile advertising and social networking, especially friend-finder services or dating services, and gaming. In the longer term, other applications will come into play within the scope of the so called Internet of Things. The challenge and opportunity for network operators will be to develop new user scenarios and even new business models to generate revenues from these services. This research uncovers opportunities that will be both beneficial and disruptive to the existing ecosystem and value chain. This research is must reading for any company that is considering offerings within proximity and direct communications and any company that wants to stay ahead of the crowd in terms of preparation for these disruptive technologies. Target Audience: ' Mobile network operators' Industry verticals of all types' Wireless device manufacturers' Network infrastructure companies' Advertising agencies, brands, and merchants' Social networks, advertising, and content providers' Proximity, location, and direct communications vendors Key Report Benefits: ' Market forecasts for each significant technology/solution approach' Recognize the upcoming role and importance of LTE Direct compared to other solutions' Analysis of the major vendors focused on proximity and direct communications solutions' Understand the relationship between proximity, direct communications and the Internet of Things' Understand the technical and business-related differences between proximity/presence and location' Identify each of the major technologies/solutions for proximity detection, location determination, and direct communications' Evaluation of the market for major applications including public safety, social networking, advertising, the Internet of Things, and general location services Select Companies in Report: ' 3M Company' Alcatel-Lucent' iSIGN' LG' Nokia' Samsung' Qualcomm' Verizon Wireless
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This document provides a summary and table of contents for a 900-page report analyzing the clinical chemistry and immunodiagnostic markets in five major European countries. The report explores trends, evaluates competitors, and identifies opportunities in these evolving markets. It contains estimates of test volumes, sales forecasts by category and country, and competitive profiles of leading suppliers.
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
Bradycardia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bradycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bradycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acid Indigestion / Heartburn/ Pyrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
This document is a report on the China iron ore mining industry in 2013. It provides an overview of the industry, including its definition and development history. It analyzes the macroeconomic environment and discusses factors like policy, upstream/downstream industries. It also examines the international and domestic markets. Key data on the industry from 2008-2012 is presented, including numbers of enterprises, employees, assets, output, sales, profits and trade. The competitive landscape and strategies of major companies are evaluated. The report concludes with discussions of development trends, investment environment and new technologies in the industry.
This document provides a summary and table of contents of the "World Biomass Report" published in November 2012. The report examines the global biomass market and finds that while it suffered during the economic downturn due to low coal prices and supply issues, the sector began growing again in 2010 as coal prices rose. Most biomass plants rely on wood pellets imported from North America, though suppliers from other regions like Russia and Australia aim to compete in the market. The full report contains detailed information on biomass resources, technologies, logistics, investments and policies on a global and national level.
This report provides an overview of the global biofuels industry in 2012. It summarizes production and policies related to first, second, and third generation biofuels in countries around the world. The report finds that 2009 was a difficult year for the biofuels industry due to low oil prices and reduced demand. However, projects using diverse feedstocks or next generation technologies like cellulosics and algae continued to receive investment. The report includes sections on biofuel production trends, technologies, environmental impacts, and policies in regions like Europe, the USA, and individual European countries.
This report analyzes the current state of various renewable energy technologies including hydropower, wind, solar, biomass, biofuels, and geothermal. It examines the market size and outlook for each technology by region, discusses the advantages and disadvantages of different renewable sources, and assesses the development status and future potential of the renewable energy industry globally. The report also profiles major renewable energy companies and evaluates government policies and industry support programs around the world.
This report provides an overview of the global solar photovoltaic (PV) market. It outlines key industry data like global solar capacity, production figures, and forecasts for future growth. It also examines major country markets and discusses the advantages, challenges, and components of the solar PV industry. The report analyzes factors such as government incentives, technology developments, and manufacturing trends that are shaping the future of the solar industry.
Inguinal Hernia Global Clinical Trials Review, H1, 2013ReportLinker.com
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Inguinal Hernia Global Clinical Trials Review, H1, 2013" provides data on the Inguinal Hernia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inguinal Hernia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inguinal Hernia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Cancer Cachexia Global Clinical Trials Review, H1, 2013ReportLinker.com
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Cancer Cachexia Global Clinical Trials Review, H1, 2013" provides data on the Cancer Cachexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cancer Cachexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cancer Cachexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Pompe Disease Global Clinical Trials Review, H1, 2013ReportLinker.com
This document summarizes a report on clinical trials for Pompe disease from January 2013. It provides an overview of the number and location of trials worldwide in the first half of 2013. The US, Germany, and China had the most trials. The trials were mostly in late phases and investigated drugs from companies like Genzyme and Sanofi. The report analyzed trial trends over time and provided profiles of top trial sponsors.
How to Implement a Real Estate CRM SoftwareSalesTown
To implement a CRM for real estate, set clear goals, choose a CRM with key real estate features, and customize it to your needs. Migrate your data, train your team, and use automation to save time. Monitor performance, ensure data security, and use the CRM to enhance marketing. Regularly check its effectiveness to improve your business.
[To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
This PowerPoint compilation offers a comprehensive overview of 20 leading innovation management frameworks and methodologies, selected for their broad applicability across various industries and organizational contexts. These frameworks are valuable resources for a wide range of users, including business professionals, educators, and consultants.
Each framework is presented with visually engaging diagrams and templates, ensuring the content is both informative and appealing. While this compilation is thorough, please note that the slides are intended as supplementary resources and may not be sufficient for standalone instructional purposes.
This compilation is ideal for anyone looking to enhance their understanding of innovation management and drive meaningful change within their organization. Whether you aim to improve product development processes, enhance customer experiences, or drive digital transformation, these frameworks offer valuable insights and tools to help you achieve your goals.
INCLUDED FRAMEWORKS/MODELS:
1. Stanford’s Design Thinking
2. IDEO’s Human-Centered Design
3. Strategyzer’s Business Model Innovation
4. Lean Startup Methodology
5. Agile Innovation Framework
6. Doblin’s Ten Types of Innovation
7. McKinsey’s Three Horizons of Growth
8. Customer Journey Map
9. Christensen’s Disruptive Innovation Theory
10. Blue Ocean Strategy
11. Strategyn’s Jobs-To-Be-Done (JTBD) Framework with Job Map
12. Design Sprint Framework
13. The Double Diamond
14. Lean Six Sigma DMAIC
15. TRIZ Problem-Solving Framework
16. Edward de Bono’s Six Thinking Hats
17. Stage-Gate Model
18. Toyota’s Six Steps of Kaizen
19. Microsoft’s Digital Transformation Framework
20. Design for Six Sigma (DFSS)
To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.AnnySerafinaLove
This letter, written by Kellen Harkins, Course Director at Full Sail University, commends Anny Love's exemplary performance in the Video Sharing Platforms class. It highlights her dedication, willingness to challenge herself, and exceptional skills in production, editing, and marketing across various video platforms like YouTube, TikTok, and Instagram.
Industrial Tech SW: Category Renewal and CreationChristian Dahlen
Every industrial revolution has created a new set of categories and a new set of players.
Multiple new technologies have emerged, but Samsara and C3.ai are only two companies which have gone public so far.
Manufacturing startups constitute the largest pipeline share of unicorns and IPO candidates in the SF Bay Area, and software startups dominate in Germany.
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Tastemy Pandit
Know what your zodiac sign says about your taste in food! Explore how the 12 zodiac signs influence your culinary preferences with insights from MyPandit. Dive into astrology and flavors!
𝐔𝐧𝐯𝐞𝐢𝐥 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐄𝐧𝐞𝐫𝐠𝐲 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐰𝐢𝐭𝐡 𝐍𝐄𝐖𝐍𝐓𝐈𝐃𝐄’𝐬 𝐋𝐚𝐭𝐞𝐬𝐭 𝐎𝐟𝐟𝐞𝐫𝐢𝐧𝐠𝐬
Explore the details in our newly released product manual, which showcases NEWNTIDE's advanced heat pump technologies. Delve into our energy-efficient and eco-friendly solutions tailored for diverse global markets.
Building Your Employer Brand with Social MediaLuanWise
Presented at The Global HR Summit, 6th June 2024
In this keynote, Luan Wise will provide invaluable insights to elevate your employer brand on social media platforms including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok. You'll learn how compelling content can authentically showcase your company culture, values, and employee experiences to support your talent acquisition and retention objectives. Additionally, you'll understand the power of employee advocacy to amplify reach and engagement – helping to position your organization as an employer of choice in today's competitive talent landscape.
Top mailing list providers in the USA.pptxJeremyPeirce1
Discover the top mailing list providers in the USA, offering targeted lists, segmentation, and analytics to optimize your marketing campaigns and drive engagement.
[To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
This presentation is a curated compilation of PowerPoint diagrams and templates designed to illustrate 20 different digital transformation frameworks and models. These frameworks are based on recent industry trends and best practices, ensuring that the content remains relevant and up-to-date.
Key highlights include Microsoft's Digital Transformation Framework, which focuses on driving innovation and efficiency, and McKinsey's Ten Guiding Principles, which provide strategic insights for successful digital transformation. Additionally, Forrester's framework emphasizes enhancing customer experiences and modernizing IT infrastructure, while IDC's MaturityScape helps assess and develop organizational digital maturity. MIT's framework explores cutting-edge strategies for achieving digital success.
These materials are perfect for enhancing your business or classroom presentations, offering visual aids to supplement your insights. Please note that while comprehensive, these slides are intended as supplementary resources and may not be complete for standalone instructional purposes.
Frameworks/Models included:
Microsoft’s Digital Transformation Framework
McKinsey’s Ten Guiding Principles of Digital Transformation
Forrester’s Digital Transformation Framework
IDC’s Digital Transformation MaturityScape
MIT’s Digital Transformation Framework
Gartner’s Digital Transformation Framework
Accenture’s Digital Strategy & Enterprise Frameworks
Deloitte’s Digital Industrial Transformation Framework
Capgemini’s Digital Transformation Framework
PwC’s Digital Transformation Framework
Cisco’s Digital Transformation Framework
Cognizant’s Digital Transformation Framework
DXC Technology’s Digital Transformation Framework
The BCG Strategy Palette
McKinsey’s Digital Transformation Framework
Digital Transformation Compass
Four Levels of Digital Maturity
Design Thinking Framework
Business Model Canvas
Customer Journey Map
SATTA MATKA SATTA FAST RESULT KALYAN TOP MATKA RESULT KALYAN SATTA MATKA FAST RESULT MILAN RATAN RAJDHANI MAIN BAZAR MATKA FAST TIPS RESULT MATKA CHART JODI CHART PANEL CHART FREE FIX GAME SATTAMATKA ! MATKA MOBI SATTA 143 spboss.in TOP NO1 RESULT FULL RATE MATKA ONLINE GAME PLAY BY APP SPBOSS
Starting a business is like embarking on an unpredictable adventure. It’s a journey filled with highs and lows, victories and defeats. But what if I told you that those setbacks and failures could be the very stepping stones that lead you to fortune? Let’s explore how resilience, adaptability, and strategic thinking can transform adversity into opportunity.
Part 2 Deep Dive: Navigating the 2024 Slowdownjeffkluth1
Introduction
The global retail industry has weathered numerous storms, with the financial crisis of 2008 serving as a poignant reminder of the sector's resilience and adaptability. However, as we navigate the complex landscape of 2024, retailers face a unique set of challenges that demand innovative strategies and a fundamental shift in mindset. This white paper contrasts the impact of the 2008 recession on the retail sector with the current headwinds retailers are grappling with, while offering a comprehensive roadmap for success in this new paradigm.
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Coloplast A/S Market Share Analysis
Published on June 2010
Report Summary
Coloplast A/S Market Share Analysis
Summary
GlobalData's medical devices report, 'Coloplast A/S Market Share Analysis' provides in-depth information on Coloplast's market
position in the different medical equipment markets it operates in. The report provides Coloplast's market share information in three
key market categories ' Advanced Wound Management, Ostomy Drainage Bags, and Incontinence Devices. The report also provides
data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with
global corporate-level profile with information on the company's business segments, major products and services, competitors,
locations and subsidiaries, financial deals and other key developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house
analysis by GlobalData's team of industry experts.
Scope
- Global company shares (in Revenues) information for the key markets Coloplast operates in ' Wound Care Management and
Nephrology and Urology Devices. Other Key players covered include ConvaTec, Coloplast, Covidien, Smith & Nephew, Ethicon,
Kinetic Concepts (KCI), Fresenius Medical Care, Svenska Celulosa Aktiebolaget SCA, Baxter International, Gambro, Kimberly-Clark,
and B. Braun Melsungen, among others.
- Coloplast's company shares (in Revenues) information for all the key countries the company has presence in ' United States,
Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Coloplast's company shares (in Revenues) information for all the key market categories the company has presence in ' Advanced
Wound Management, Ostomy Drainage Bags, and Incontinence Devices.
- All the key data-points are for 2009 and cover all the key regions ' North America, Europe, Asia Pacific (APAC), South Central
America (SCA), and Middle East and Africa (MEA).
- Global corporate-level profile with information on the company's business segments, major products and services, competitors, and
locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value
proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any ' Mergers & Acquisitions
(M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.
Reasons to buy
- Develop sales and marketing strategies by identifying who-stands-where in the markets, Coloplast operates in.
- Plan your competition strategies by identifying the company's shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are
involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in
Coloplast A/S Market Share Analysis Page 1/10
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not
limited to Coloplast's market positions.
Table of Content
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 12
2.1 What Is This Report About' 12
3 Definitions of Markets/Categories Covered 13
3.1 Wound Care Management 13
3.1.1 Advanced Wound Management 13
3.1.2 Ostomy Drainage Bags 13
3.2 Nephrology and Urology Devices 13
3.2.1 Incontinence Devices 13
4 Company Snapshot 14
4.1 Key Information 14
4.2 Company Overview 14
4.3 Financial Performance 14
4.4 SWOT Snapshot 14
5 Business Description 15
5.1 Business Overview 15
5.2 Medical Care 15
5.2.1 Overview 15
5.2.2 Financials 15
5.2.3 Market View 15
5.2.4 Key Strategies 16
5.3 Major Products and Services 17
5.3.1 Overview 17
6 History 18
7 SWOT Analysis 20
7.1 Overview 20
7.2 Coloplast A/S Strengths 21
7.2.1 Agreement with Caldera Medical 21
7.2.2 Focused Research and Development 21
7.2.3 Efficient Use of Resources 21
7.3 Coloplast A/S Weaknesses 21
7.3.1 Limited Liquidity Position 21
7.3.2 Product Recalls 21
7.3.3 Dependence on the European Market 21
7.4 Coloplast A/S Opportunities 22
7.4.1 Growing Urology Market 22
7.4.2 New Facilities 22
7.4.3 Product Launches 22
7.4.4 Market Growth in Emerging Economies 22
7.5 Coloplast A/S Threats 23
Coloplast A/S Market Share Analysis Page 2/10
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
11.6.1 Coloplast A/S, Brazil, Category Revenue Share (2009) 109
11.6.2 Coloplast A/S, Other South and Central America, Category Revenue Share (2009) 111
12 Key Employees 113
13 Key Employee Biographies 114
14 Company Statement 115
15 Locations And Subsidiaries 117
15.1 Head Office 117
15.2 Other Locations & Subsidiaries 117
16 Financial Deals Landscape 119
16.1 Coloplast A/S, Deals Volume Summary, 2005 to YTD 2010 119
17 Coloplast A/S Detailed Deal Summary 121
17.1 Asset Purchase 121
17.1.1 Coloplast Acquires Surgical Urology and Clinical And Consumer Healthcare Business Segments Of Mentor 121
17.2 Partnerships 123
17.2.1 Smith & Nephew Signs Agreement with Coloplast 123
17.2.2 Caldera Medical Enters Into Licensing Agreement with Coloplast 124
17.2.3 Coloplast and Aalborg University Forms Acarix 125
17.2.4 Coloplast Signs Distribution Agreement with Carbon Medical Technologies 126
17.2.5 Tutogen Medical Enters Into a Distribution Agreement with Coloplast 127
17.3 Divestiture - Company 128
17.3.1 Core Oncology Acquires Mills Biopharmaceuticals from Coloplast 128
17.3.2 McKesson Corporation Acquires Sterling Medical Services from Coloplast 130
17.4 Divestiture - Assets 132
17.4.1 SRS Medical Acquires EvaCare Line of Pessaries from Coloplast 132
17.5 Acquisition 134
17.5.1 Interface Biotech Receives an Investment from Coloplast 134
18 Appendix 136
18.1 Research Methodology 137
18.2 Secondary Research 138
18.3 Primary Research 138
18.4 Models 139
18.5 Forecasts 139
18.6 Expert Panels 139
18.7 GlobalData Consulting 139
18.8 Currency Conversion 140
18.9 Contact Us 141
18.10 Disclaimer 141
1.1 List of Tables
Table 1: Coloplast A/S, Key Facts, 2009 14
Table 2: Coloplast A/S, SWOT Analysis, 2009 20
Table 3: Wound Care Management, Global, Company Share by Revenue ($m), 2009 26
Table 4: Nephrology and Urology Devices, Global, Company Share by Revenue ($m), 2009 28
Table 5: Coloplast A/S, Medical Equipment, Global, Revenue ($m) and Market Share (%), 2009 30
Table 6: Coloplast A/S, Medical Equipment, Asia-Pacific, Revenue ($m) and Market Share (%), 2009 32
Table 7: Coloplast A/S, Medical Equipment, Australia, Revenue ($m) and Market Share (%), 2009 34
Table 8: Coloplast A/S, Medical Equipment, China, Revenue ($m) and Market Share (%), 2009 36
Table 9: Coloplast A/S, Medical Equipment, India, Revenue ($m) and Market Share (%), 2009 38
Table 10: Coloplast A/S, Medical Equipment, Japan, Revenue ($m) and Market Share (%), 2009 40
Table 11: Coloplast A/S, Medical Equipment, Other Asia-Pacific, Revenue ($m) and Market Share (%), 2009 42
Coloplast A/S Market Share Analysis Page 4/10
5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 12: Coloplast A/S, Medical Equipment, Europe, Revenue ($m) and Market Share (%), 2009 44
Table 13: Coloplast A/S, Medical Equipment, France, Revenue ($m) and Market Share (%), 2009 46
Table 14: Coloplast A/S, Medical Equipment, Germany, Revenue ($m) and Market Share (%), 2009 48
Table 15: Coloplast A/S, Medical Equipment, Italy, Revenue ($m) and Market Share (%), 2009 50
Table 16: Coloplast A/S, Medical Equipment, Spain, Revenue ($m) and Market Share (%), 2009 52
Table 17: Coloplast A/S, Medical Equipment, United Kingdom, Revenue ($m) and Market Share (%), 2009 54
Table 18: Coloplast A/S, Medical Equipment, Other Europe, Revenue ($m) and Market Share (%), 2009 56
Table 19: Coloplast A/S, Medical Equipment, Middle East and Africa, Revenue ($m) and Market Share (%), 2009 58
Table 20: Coloplast A/S, Medical Equipment, North America, Revenue ($m) and Market Share (%), 2009 60
Table 21: Coloplast A/S, Medical Equipment, Canada, Revenue ($m) and Market Share (%), 2009 62
Table 22: Coloplast A/S, Medical Equipment, United States, Revenue ($m) and Market Share (%), 2009 64
Table 23: Coloplast A/S, Medical Equipment, South and Central America, Revenue ($m) and Market Share (%), 2009 66
Table 24: Coloplast A/S, Medical Equipment, Brazil, Revenue ($m) and Market Share (%), 2009 68
Table 25: Coloplast A/S, Medical Equipment, Other South and Central America, Revenue ($m) and Market Share (%), 2009 70
Table 26: Coloplast A/S, Medical Equipment, Global, Revenue ($m) and Market Share (%) by Category, 2009 72
Table 27: Coloplast A/S, Medical Equipment, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2009 74
Table 28: Coloplast A/S, Medical Equipment, Australia, Revenue ($m) and Market Share (%) by Category, 2009 76
Table 29: Coloplast A/S, Medical Equipment, China, Revenue ($m) and Market Share (%) by Category, 2009 78
Table 30: Coloplast A/S, Medical Equipment, India, Revenue ($m) and Market Share (%) by Category, 2009 80
Table 31: Coloplast A/S, Medical Equipment, Japan, Revenue ($m) and Market Share (%) by Category, 2009 82
Table 32: Coloplast A/S, Medical Equipment, Other Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2009 84
Table 33: Coloplast A/S, Medical Equipment, Europe, Revenue ($m) and Market Share (%) by Category, 2009 86
Table 34: Coloplast A/S, Medical Equipment, France, Revenue ($m) and Market Share (%) by Category, 2009 88
Table 35: Coloplast A/S, Medical Equipment, Germany, Revenue ($m) and Market Share (%) by Category, 2009 90
Table 36: Coloplast A/S, Medical Equipment, Italy, Revenue ($m) and Market Share (%) by Category, 2009 92
Table 37: Coloplast A/S, Medical Equipment, Spain, Revenue ($m) and Market Share (%) by Category, 2009 94
Table 38: Coloplast A/S, Medical Equipment, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2009 96
Table 39: Coloplast A/S, Medical Equipment, Other Europe, Revenue ($m) and Market Share (%) by Category, 2009 98
Table 40: Coloplast A/S, Medical Equipment, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2009 100
Table 41: Coloplast A/S, Medical Equipment, North America, Revenue ($m) and Market Share (%) by Category, 2009 102
Table 42: Coloplast A/S, Medical Equipment, Canada, Revenue ($m) and Market Share (%) by Category, 2009 104
Table 43: Coloplast A/S, Medical Equipment, United States, Revenue ($m) and Market Share (%) by Category, 2009 106
Table 44: Coloplast A/S, Medical Equipment, South and Central America, Revenue ($m) and Market Share (%) by Category, 2009
108
Table 45: Coloplast A/S, Medical Equipment, Brazil, Revenue ($m) and Market Share (%) by Category, 2009 110
Table 46: Coloplast A/S, Medical Equipment, Other South and Central America, Revenue ($m) and Market Share (%) by
Category, 2009 112
Table 47: Coloplast A/S, Key Employees 113
Table 48: Coloplast A/S, Other Locations 117
Table 49: Coloplast A/S, Subsidiaries 117
Table 50: Coloplast A/S, Deals Volume Summary, 2005 to YTD 2010 119
Table 51: Coloplast A/S, Deals Summary, 2005 to YTD 2010 120
Table 52: Coloplast Acquires Surgical Urology And Clinical And Consumer Healthcare Business Segments Of Mentor 121
Table 53: Smith & Nephew Signs Agreement With Coloplast 123
Table 54: Caldera Medical Enters Into Licensing Agreement With Coloplast 124
Table 55: Coloplast And Aalborg University Forms Acarix 125
Table 56: Coloplast Signs Distribution Agreement With Carbon Medical Technologies 126
Table 57: Tutogen Medical Enters Into A Distribution Agreement With Coloplast 127
Table 58: Core Oncology Acquires Mills Biopharmaceuticals From Coloplast 128
Table 59: McKesson Corporation Acquires Sterling Medical Services From Coloplast 130
Coloplast A/S Market Share Analysis Page 5/10
6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 60: SRS Medical Acquires EvaCare Line Of Pessaries From Coloplast 132
Table 61: Interface Biotech Receives An Investment From Coloplast 134
Table 62: USD to Local Currency, Average Exchange Rate 2009 140
1.2 List of Figures
Figure 1: Wound Care Management, Global, Company Share (%), 2009 25
Figure 2: Nephrology and Urology Devices, Global, Company Share (%), 2009 27
Figure 3: Coloplast A/S, Medical Equipment, Global, Revenue Share (%), 2009 29
Figure 4: Coloplast A/S, Medical Equipment, Global, Market Share (%), 2009 30
Figure 5: Coloplast A/S, Medical Equipment, Asia-Pacific, Revenue Share (%), 2009 31
Figure 6: Coloplast A/S, Medical Equipment, Asia-Pacific, Market Share (%), 2009 32
Figure 7: Coloplast A/S, Medical Equipment, Australia, Revenue Share (%), 2009 33
Figure 8: Coloplast A/S, Medical Equipment, Australia, Market Share (%), 2009 34
Figure 9: Coloplast A/S, Medical Equipment, China, Revenue Share (%), 2009 35
Figure 10: Coloplast A/S, Medical Equipment, China, Market Share (%), 2009 36
Figure 11: Coloplast A/S, Medical Equipment, India, Revenue Share (%), 2009 37
Figure 12: Coloplast A/S, Medical Equipment, India, Market Share (%), 2009 38
Figure 13: Coloplast A/S, Medical Equipment, Japan, Revenue Share (%), 2009 39
Figure 14: Coloplast A/S, Medical Equipment, Japan, Market Share (%), 2009 40
Figure 15: Coloplast A/S, Medical Equipment, Other Asia-Pacific, Revenue Share (%), 2009 41
Figure 16: Coloplast A/S, Medical Equipment, Other Asia-Pacific, Market Share (%), 2009 42
Figure 17: Coloplast A/S, Medical Equipment, Europe, Revenue Share (%), 2009 43
Figure 18: Coloplast A/S, Medical Equipment, Europe, Market Share (%), 2009 44
Figure 19: Coloplast A/S, Medical Equipment, France, Revenue Share (%), 2009 45
Figure 20: Coloplast A/S, Medical Equipment, France, Market Share (%), 2009 46
Figure 21: Coloplast A/S, Medical Equipment, Germany, Revenue Share (%), 2009 47
Figure 22: Coloplast A/S, Medical Equipment, Germany, Market Share (%), 2009 48
Figure 23: Coloplast A/S, Medical Equipment, Italy, Revenue Share (%), 2009 49
Figure 24: Coloplast A/S, Medical Equipment, Italy, Market Share (%), 2009 50
Figure 25: Coloplast A/S, Medical Equipment, Spain, Revenue Share (%), 2009 51
Figure 26: Coloplast A/S, Medical Equipment, Spain, Market Share (%), 2009 52
Figure 27: Coloplast A/S, Medical Equipment, United Kingdom, Revenue Share (%), 2009 53
Figure 28: Coloplast A/S, Medical Equipment, United Kingdom, Market Share (%), 2009 54
Figure 29: Coloplast A/S, Medical Equipment, Other Europe, Revenue Share (%), 2009 55
Figure 30: Coloplast A/S, Medical Equipment, Other Europe, Market Share (%), 2009 56
Figure 31: Coloplast A/S, Medical Equipment, Middle East and Africa, Revenue Share (%), 2009 57
Figure 32: Coloplast A/S, Medical Equipment, Middle East and Africa, Market Share (%), 2009 58
Figure 33: Coloplast A/S, Medical Equipment, North America, Revenue Share (%), 2009 59
Figure 34: Coloplast A/S, Medical Equipment, North America, Market Share (%), 2009 60
Figure 35: Coloplast A/S, Medical Equipment, Canada, Revenue Share (%), 2009 61
Figure 36: Coloplast A/S, Medical Equipment, Canada, Market Share (%), 2009 62
Figure 37: Coloplast A/S, Medical Equipment, United States, Revenue Share (%), 2009 63
Figure 38: Coloplast A/S, Medical Equipment, United States, Market Share (%), 2009 64
Figure 39: Coloplast A/S, Medical Equipment, South and Central America, Revenue Share (%), 2009 65
Figure 40: Coloplast A/S, Medical Equipment, South and Central America, Market Share (%), 2009 66
Figure 41: Coloplast A/S, Medical Equipment, Brazil, Revenue Share (%), 2009 67
Figure 42: Coloplast A/S, Medical Equipment, Brazil, Market Share (%), 2009 68
Figure 43: Coloplast A/S, Medical Equipment, Other South and Central America, Revenue Share (%), 2009 69
Figure 44: Coloplast A/S, Medical Equipment, Other South and Central America, Market Share (%), 2009 70
Figure 45: Coloplast A/S, Medical Equipment, Global, Category Revenue Share (%), 2009 71
Coloplast A/S Market Share Analysis Page 6/10
7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Figure 46: Coloplast A/S, Medical Equipment, Global, Market Share (%) by Category, 2009 72
Figure 47: Coloplast A/S, Medical Equipment, Asia-Pacific, Category Revenue Share (%), 2009 73
Figure 48: Coloplast A/S, Medical Equipment, Asia-Pacific, Market Share (%) by Category, 2009 74
Figure 49: Coloplast A/S, Medical Equipment, Australia, Category Revenue Share (%), 2009 75
Figure 50: Coloplast A/S, Medical Equipment, Australia, Market Share (%) by Category, 2009 76
Figure 51: Coloplast A/S, Medical Equipment, China, Category Revenue Share (%), 2009 77
Figure 52: Coloplast A/S, Medical Equipment, China, Market Share (%) by Category, 2009 78
Figure 53: Coloplast A/S, Medical Equipment, India, Category Revenue Share (%), 2009 79
Figure 54: Coloplast A/S, Medical Equipment, India, Market Share (%) by Category, 2009 80
Figure 55: Coloplast A/S, Medical Equipment, Japan, Category Revenue Share (%), 2009 81
Figure 56: Coloplast A/S, Medical Equipment, Japan, Market Share (%) by Category, 2009 82
Figure 57: Coloplast A/S, Medical Equipment, Other Asia-Pacific, Category Revenue Share (%), 2009 83
Figure 58: Coloplast A/S, Medical Equipment, Other Asia-Pacific, Market Share (%) by Category, 2009 84
Figure 59: Coloplast A/S, Medical Equipment, Europe, Category Revenue Share (%), 2009 85
Figure 60: Coloplast A/S, Medical Equipment, Europe, Market Share (%) by Category, 2009 86
Figure 61: Coloplast A/S, Medical Equipment, France, Category Revenue Share (%), 2009 87
Figure 62: Coloplast A/S, Medical Equipment, France, Market Share (%) by Category, 2009 88
Figure 63: Coloplast A/S, Medical Equipment, Germany, Category Revenue Share (%), 2009 89
Figure 64: Coloplast A/S, Medical Equipment, Germany, Market Share (%) by Category, 2009 90
Figure 65: Coloplast A/S, Medical Equipment, Italy, Category Revenue Share (%), 2009 91
Figure 66: Coloplast A/S, Medical Equipment, Italy, Market Share (%) by Category, 2009 92
Figure 67: Coloplast A/S, Medical Equipment, Spain, Category Revenue Share (%), 2009 93
Figure 68: Coloplast A/S, Medical Equipment, Spain, Market Share (%) by Category, 2009 94
Figure 69: Coloplast A/S, Medical Equipment, United Kingdom, Category Revenue Share (%), 2009 95
Figure 70: Coloplast A/S, Medical Equipment, United Kingdom, Market Share (%) by Category, 2009 96
Figure 71: Coloplast A/S, Medical Equipment, Other Europe, Category Revenue Share (%), 2009 97
Figure 72: Coloplast A/S, Medical Equipment, Other Europe, Market Share (%) by Category, 2009 98
Figure 73: Coloplast A/S, Medical Equipment, Middle East and Africa, Category Revenue Share (%), 2009 99
Figure 74: Coloplast A/S, Medical Equipment, Middle East and Africa, Market Share (%) by Category, 2009 100
Figure 75: Coloplast A/S, Medical Equipment, North America, Category Revenue Share (%), 2009 101
Figure 76: Coloplast A/S, Medical Equipment, North America, Market Share (%) by Category, 2009 102
Figure 77: Coloplast A/S, Medical Equipment, Canada, Category Revenue Share (%), 2009 103
Figure 78: Coloplast A/S, Medical Equipment, Canada, Market Share (%) by Category, 2009 104
Figure 79: Coloplast A/S, Medical Equipment, United States, Category Revenue Share (%), 2009 105
Figure 80: Coloplast A/S, Medical Equipment, United States, Market Share (%) by Category, 2009 106
Figure 81: Coloplast A/S, Medical Equipment, South and Central America, Category Revenue Share (%), 2009 107
Figure 82: Coloplast A/S, Medical Equipment, South and Central America, Market Share (%) by Category, 2009 108
Figure 83: Coloplast A/S, Medical Equipment, Brazil, Category Revenue Share (%), 2009 109
Figure 84: Coloplast A/S, Medical Equipment, Brazil, Market Share (%) by Category, 2009 110
Figure 85: Coloplast A/S, Medical Equipment, Other South and Central America, Category Revenue Share (%), 2009 111
Figure 86: Coloplast A/S, Medical Equipment, Other South and Central America, Market Share (%) by Category, 2009 112
Figure 87: Coloplast A/S, Deals Volume Summary, 2005 to YTD 2010 119
Figure 88: GlobalData Methodology 137
Companies mentioned3M Health Care
Asahi Kasei Corporation
AstraZeneca PLC
B. Braun Melsungen AG
Baxter International Inc.
C. R. Bard, Inc.
Coloplast A/S Market Share Analysis Page 7/10
8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
ConvaTec
Covidien plc
Ethicon, Inc.
Fresenius Medical Care AG & Co. KGaA
Gambro AB
Hartmann Group
Hill-Rom, Inc.
Hollister Incorporated
Huntleigh Healthcare Ltd
Johnson & Johnson
Kimberly-Clark Corporation
Kinetic Concepts, Inc.
Molnlycke Health Care AB
NIPRO CORPORATION
Ontex N.V.
Smith & Nephew Plc
Svenska Celulosa Aktiebolaget SCA
Teleflex Incorporated
Tyco Healthcare/Kendall
Unicharm Corporation
Coloplast A/S Market Share Analysis Page 8/10
9. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Coloplast A/S Market Share Analysis
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 000.00 Quantity: _____
Site License--USD 2 000.00 Quantity: _____
Corporate License--USD 3 000.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Coloplast A/S Market Share Analysis Page 9/10
10. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Coloplast A/S Market Share Analysis Page 10/10